$-0.10 EPS Expected for TherapeuticsMD, Inc. (TXMD); Seaboard (NYSEAMERICAN:SEB) Shorts Raised By 40.62%

April 19, 2018 - By Marie Mckinney

Seaboard Corporation (NYSEAMERICAN:SEB) Logo

Seaboard Corporation (NYSEAMERICAN:SEB) had an increase of 40.62% in short interest. SEB’s SI was 4,500 shares in April as released by FINRA. Its up 40.62% from 3,200 shares previously. With 400 avg volume, 11 days are for Seaboard Corporation (NYSEAMERICAN:SEB)’s short sellers to cover SEB’s short positions. The SI to Seaboard Corporation’s float is 1.7%. The stock decreased 0.65% or $26.64 during the last trading session, reaching $4100. About 520 shares traded or 63.01% up from the average. Seaboard Corporation (NYSEAMERICAN:SEB) has risen 6.93% since April 19, 2017 and is uptrending. It has underperformed by 4.62% the S&P500.

Analysts expect TherapeuticsMD, Inc. (NASDAQ:TXMD) to report $-0.10 EPS on May, 1.They anticipate $0.01 EPS change or 9.09% from last quarter’s $-0.11 EPS. After having $-0.10 EPS previously, TherapeuticsMD, Inc.’s analysts see 0.00% EPS growth. The stock increased 1.75% or $0.1 during the last trading session, reaching $5.82. About 1.88 million shares traded. TherapeuticsMD, Inc. (NASDAQ:TXMD) has declined 30.29% since April 19, 2017 and is downtrending. It has underperformed by 41.84% the S&P500.

TherapeuticsMD, Inc. operates as a women's health care product company. The company has market cap of $1.26 billion. The firm makes and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, and natural menopause relief products under the vitaMedMD brand, as well as generic formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. It currently has negative earnings. The Company’s pipeline of hormone therapy drug candidates include TX-001HR, a combination of estradiol and progesterone drug candidate under clinical trials for the treatment of moderate to severe vasomotor symptoms due to menopause; TX-002HR, a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil; and TX-004HR, an applicator-free vaginal estradiol softgel drug candidate for the treatment of vulvar and vaginal atrophy in post-menopausal women with vaginal linings that do not receive enough estrogen.

Investors sentiment decreased to 1.62 in 2017 Q4. Its down 0.11, from 1.73 in 2017Q3. It dived, as 17 investors sold TherapeuticsMD, Inc. shares while 25 reduced holdings. 22 funds opened positions while 46 raised stakes. 159.91 million shares or 1.31% less from 162.04 million shares in 2017Q3 were reported. Morgan Stanley has invested 0% in TherapeuticsMD, Inc. (NASDAQ:TXMD). Group invested in 111,592 shares. Impact Advsrs Lc reported 200,707 shares. Northern has invested 0% of its portfolio in TherapeuticsMD, Inc. (NASDAQ:TXMD). The New York-based Sg Americas Secs Ltd Liability Company has invested 0.01% in TherapeuticsMD, Inc. (NASDAQ:TXMD). Cetera Advsr Limited Liability holds 0.02% or 48,650 shares. Voya Management Lc invested in 0.04% or 3.32M shares. Goldman Sachs Grp invested 0% in TherapeuticsMD, Inc. (NASDAQ:TXMD). Citigroup Inc stated it has 19,906 shares or 0% of all its holdings. State Street Corporation, Massachusetts-based fund reported 3.91M shares. First Eagle Investment Mgmt Lc holds 0.02% in TherapeuticsMD, Inc. (NASDAQ:TXMD) or 1.57M shares. Bank & Trust Of America De, a North Carolina-based fund reported 50,494 shares. Ardsley Advisory Ptnrs owns 1.05 million shares. 17.43M were accumulated by Price T Rowe Md. Parametric Associate Limited stated it has 0% in TherapeuticsMD, Inc. (NASDAQ:TXMD).

Seaboard Corporation operates as a diverse agribusiness and transportation firm worldwide. The company has market cap of $4.80 billion. The Company’s Pork division is involved in hog production and pork processing; and the production and sale of fresh and frozen pork products to further processors, foodservice operators, grocery stores, distributors, and retail outlets. It has a 19.43 P/E ratio. This division sells its fresh products under the Prairie Fresh brand; and raw and pre-cooked bacon, ham, and sausage under the DailyÂ’s brand.

TherapeuticsMD, Inc. (NASDAQ:TXMD) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>